News & Events

  • October 08, 2012

    Trig Acqusition 1, Inc., held an initial closing in the amount of $1,050,000 regarding a best efforts private placement offering of up to $5,000,000. Grandview Capital Partners Inc. acted as placement agent for the offering. Simultaneous with the initial closing of the Offering, Trig Acquisition 1, Inc. also entered into a share exchange agreement whereby it acquired, through a reverse merger, Grilled Cheese Inc. EG&S represented the placement agent in the alternative public offering.

  • October 03, 2012

    RLJ Acquisition Inc. Announces Succesful Completion of its Business Combination

    RLJ Acquisition, Inc., a special purpose acquisition vehicle, announced the closing of its business combination with Image Entertainment, Inc. and Acorn Media Group, Inc., two media content distribution companies, to form RLJ Entertainment, Inc., one of the largest independent global distributors of digital and video content. EG&S acted as counsel to Image’s Special Committee.

    RLJ Companies, October 3, 2012

  • October 01, 2012

    CombiMatrix Corporation announced the closing of their Private Placement offering in the amount of $1,050,875.49.  EG&S acted as counsel to the Investor.

  • October 01, 2012

    Wealth Management Systems Inc. announced the closing of its acquisition of 100% of the equity interests in Archimedes Systems, Inc.  EG&S acted as counsel to Wealth Management.

  • September 14, 2012

    Hemispherx Biopharma, Inc. announced the closing of their At the Market Offering in the amount of $75,000,000.  EG&S acted as counsel to the Selling Agent.
     

  • September 10, 2012

    rVue Holdings, Inc. announced the closing of their  PIPE financing in the amount of $1,200,000 and concurrent conversion of $1,800,000 of debt.  EG&S acted as counsel to rVue.

  • September 05, 2012

    In response to FINRA’s proposed guidelines, Ellenoff Grossman & Schole LLP has submitted the comment letter below.

    Click here to read the comment letter

  • September 05, 2012

    Crowdfund Capital Advisors has written a whitepaper titled "How Crowdfund Investing Helps Solve Three Pressing Socioeconomic Challenges."  EG&S sponsored the whitepaper.

    Click here to read the whitepaper

  • August 20, 2012

    BioSante Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $3,474,999. EG&S acted as counsel to the placement agent.

  • August 15, 2012

    Arrowhead Research Corp. announced the closing of their Registered Direct offering in the amount of $6,240,000.  EG&S acted as counsel to the placement agent.

  • August 14, 2012

    Generex Biotechnology Corporation announced the closing of their Registered Direct offering in the amount of $750,000.  EG&S acted as counsel to the Investor.

  • August 13, 2012

    Eco Building Products, Inc. announced the closing of their PIPE offering in the amount of $1,080,000.  EG&S acted as counsel to the Investor.

  • August 08, 2012

    ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $952,710.  EG&S acted as counsel to the placement agent.

  • August 07, 2012

    pSivida Corp. announced the closing of their Registered Direct offering in the amount of $5,363,000. EG&S acted as counsel to the placement agent.

  • August 06, 2012

    Stevia Corp. announced the closing of their PIPE offering in the amount of $500,000.  EG&S acted as counsel to the Investor.

  • July 31, 2012

    NutraCea announced the closing of their PIPE offering in the amount of $290,000.  EG&S acted as counsel to the Investor.

  • July 26, 2012

    Infinity Cross Border AcquisitionCorporation (Nasdaq: INXBU) announced the closing of their SPAC IPO in the amount of $40,000,000. EG&S acted as counsel to Infinity.

  • July 20, 2012

    Saul H. Finkelstein, a member of the Firm, participated in a webinar on M&A Confidentiality Agreements. The panel reviewed the latest developments with non-disclosure agreements, examined key elements of the agreement, and offered negotiation approaches for sellers and buyers.

  • July 20, 2012

    Brianstorm Cell Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $972,500.  EG&S acted as counsel to the placement agent.

  • July 19, 2012

    Assured Pharmacy, Inc. announced the closing of their Private Placement offering in the amount of $300,000. EG&S acted as counsel to the Investor.

  • July 19, 2012

    IsoRay, Inc. announced the closing of their Registered Direct offering in the amount of $3,500,000.  EG&S acted as counsel to the placement agent.

  • July 19, 2012

    Douglas S. Ellenoff, a member of the Firm, participated in “The Crowdfund Act – Framing the new regulatory landscape Symposium” sponsored in Washington by the Crowdfund Intermediary Regulatory Advocates (CFIRA). Mr. Ellenoff spoke on two different panels: The Mechanics of a Crowdfund Offering and Reaching the Crowd.

    Click here for more details

  • July 06, 2012

    MYOS Corporation announced the closing of their PIPE offering in the amount of $5,600,000. EG&S acted as counsel to MYOS Corporation.

  • July 02, 2012

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for the first half of 2012.

    Click here to view the rankings

  • June 22, 2012

    Mr. Douglas S. Ellenoff, a member of the Firm, participated in an invitation only JOBS Act Roundtable at New York University.  Among the invitees were Josh Bonnie, partner at Simpson, Thacher & Bartlett; Tim Bowler, Deputy Assistant Secretary for Capital Markets, Treasury; Ryan Bubb, professor, NYU School of Law; Robert Buckholz, partner at Sullivan & Cromwell; Reggie Chambers, White House Fellow, White House National Economic Council; Eric Froman, Attorney-Advisor, Office of the Assistant General Counsel (Banking & Finance), Treasury; Don Graves, Deputy Assistant Secretary for Small Business, Community Development, and Affordable Housing Policy, Treasury; Katherine Harris, Policy Advisor, Office of Financial Institutions, Treasury; Joan Macleod Hemingway, Professor, University of Tennessee College of Law; Kevin Laws, Chief Operating Officer, AngelList; Barbara Novick, Vice Chairman, Blackrock; Douglas Rand, Senior Policy Advisor, White House Office of Science and Technology Policy; and Jeff Rubin, Partner at Hogan Lovells.